T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Schlumberger
SLB
|
+$2.5B |
| 2 |
Kenvue
KVUE
|
+$1.3B |
| 3 |
Halliburton
HAL
|
+$1.16B |
| 4 |
Charles Schwab
SCHW
|
+$836M |
| 5 |
Boeing
BA
|
+$832M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.52B |
| 2 |
Apple
AAPL
|
+$1.77B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.57B |
| 4 |
Johnson & Johnson
JNJ
|
+$1.47B |
| 5 |
Intuit
INTU
|
+$1.14B |
Sector Composition
| 1 | Technology | 29.85% |
| 2 | Healthcare | 16.84% |
| 3 | Financials | 10.89% |
| 4 | Consumer Discretionary | 10.77% |
| 5 | Communication Services | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
American Superconductor
AMSC
$2.37B
| $128K | ﹤0.01% |
16,911
-19,489
| -54% | -$148K |
|
2602
Ocular Therapeutix
OCUL
$2.22B
| $128K | ﹤0.01% |
40,485
+1,846
| +5% | +$5.84K |
|
|
BIG
2603
DELISTED
Big Lots, Inc.
BIG
| $128K | ﹤0.01% |
24,918
+381
| +2% | +$1.96K |
|
2604
Atea Pharmaceuticals
AVIR
$250M
| $127K | ﹤0.01% |
42,242
+1,010
| +2% | +$3.04K |
|
2605
Pixelworks
PXLW
$63.9M
| $126K | ﹤0.01% |
9,292
| – | – |
|
2606
Ring Energy
REI
$207M
| $126K | ﹤0.01% |
64,179
| – | – |
|
2607
Hippo Holdings
HIPO
$902M
| $125K | ﹤0.01% |
15,627
+177
| +1% | +$1.42K |
|
2608
Evolv Technologies
EVLV
$1.39B
| $124K | ﹤0.01% |
25,353
+2,520
| +11% | +$12.3K |
|
|
GMRE
2609
Global Medical REIT
GMRE
$509M
| $124K | ﹤0.01% |
13,786
+1,507
| +12% | +$13.6K |
|
|
OPI
2610
Office Properties Income Trust
OPI
$17.5M
| $123K | ﹤0.01% |
29,929
-15,649
| -34% | -$64.3K |
|
2611
Arcutis Biotherapeutics
ARQT
$2.1B
| $122K | ﹤0.01% |
22,947
+622
| +3% | +$3.31K |
|
|
EBIX
2612
DELISTED
Ebix Inc
EBIX
| $121K | ﹤0.01% |
12,211
-35,877
| -75% | -$356K |
|
2613
Innodata
INOD
$1.87B
| $120K | ﹤0.01% |
13,959
-1,561
| -10% | -$13.4K |
|
2614
Great Lakes Dredge & Dock
GLDD
$809M
| $118K | ﹤0.01% |
14,802
+1,286
| +10% | +$10.3K |
|
2615
Stoke Therapeutics
STOK
$1.22B
| $118K | ﹤0.01% |
29,789
-329,133
| -92% | -$1.3M |
|
2616
Karyopharm Therapeutics
KPTI
$56M
| $117K | ﹤0.01% |
5,808
+1,267
| +28% | +$25.5K |
|
2617
AST SpaceMobile
ASTS
$10.1B
| $116K | ﹤0.01% |
30,454
+5,165
| +20% | +$19.7K |
|
2618
SGHC Ltd
SGHC
$6.61B
| $116K | ﹤0.01% |
31,285
+3,625
| +13% | +$13.4K |
|
2619
Tango Therapeutics
TNGX
$724M
| $116K | ﹤0.01% |
+10,216
| New | +$116K |
|
2620
Energy Vault
NRGV
$301M
| $114K | ﹤0.01% |
44,584
+2,959
| +7% | +$7.57K |
|
|
LGF.A
2621
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $114K | ﹤0.01% |
13,415
+1,647
| +14% | +$14K |
|
2622
ClearPoint Neuro
CLPT
$304M
| $113K | ﹤0.01% |
22,366
| – | – |
|
2623
Heritage Commerce
HTBK
$627M
| $113K | ﹤0.01% |
13,268
+1,348
| +11% | +$11.5K |
|
|
VOXX
2624
DELISTED
VOXX International Corporation Class A
VOXX
| $113K | ﹤0.01% |
14,127
| – | – |
|
2625
Standard BioTools
LAB
$493M
| $112K | ﹤0.01% |
38,400
| – | – |
|